OTCQX | Jotup

AYR Wellness Announces Upsizing of Gainesville Cultivation Facility Mortgage

Retrieved on:

Tuesday, March 26, 2024

MIAMI, March 26, 2024 (GLOBE NEWSWIRE) -- AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator (“MSO”), today announced that it has closed on a $8.4 million upsizing of its existing mortgage for its Gainesville cultivation facility (the “Facility”), increasing the principal amount of the mortgage to $48.4M.

Key Points:

MIAMI, March 26, 2024 (GLOBE NEWSWIRE) -- AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator (“MSO”), today announced that it has closed on a $8.4 million upsizing of its existing mortgage for its Gainesville cultivation facility (the “Facility”), increasing the principal amount of the mortgage to $48.4M.
Proceeds will be used to invest further in the Facility and the Company’s Florida business, as well as for general working capital purposes.
Aside from the upsizing, there were no other changes to the terms of the mortgage, including the interest rate or the maturity date in 2033.
Brad Asher, Chief Financial Officer at AYR Wellness, said, “This upsizing further strengthens our balance sheet with additional capital at competitive rates and longer-term maturity.

Empowering Success, Sustainable Green Team, Ltd. (SGTM) Strengthens Leadership Roles with Key Executives and Advisors to Drive and Power Sustainable Growth

Retrieved on:

Tuesday, March 26, 2024

Strategic management, Climate change, Growth, Environment, Recycling, CFO, Knowledge, Climate, Strategic planning, Green Team, Food security, Entrepreneurship, Investment, OTCQX, Advertising, Marketing, Consultant, Management

As a global powerhouse organization, with experienced executives and advisors working together, the Company is preparing for the opportunities and successful accomplishments that lie ahead.

Key Points:

As a global powerhouse organization, with experienced executives and advisors working together, the Company is preparing for the opportunities and successful accomplishments that lie ahead.
Sustainable Green Team, Ltd. introduces the following executives and consultants:
- Barry Pape nfuss has been appointed as the Chief Financial Officer (CFO) for SGTM.
His expertise in strategy, investments, and leadership in food security will be invaluable to the company's sustainable growth.
"Their diverse backgrounds and expertise will be instrumental in driving our sustainable growth and making a positive impact on the environment."

PharmAla Biotech Signs Sale Agreement with Numinus

Retrieved on:

Tuesday, March 26, 2024

MDXX, MBDB, GMP, TSX, OTCQX, Clinical trial, OTC, MDMA, ABA, Biology, Poster, Pharmaceutical industry

TORONTO, March 26, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA, OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to announce that it had entered into a binding sales agreement with Numinus Wellness Inc. (“Numinus”) (TSX: NUMI, OTCQX: NUMIF) to provide its GMP LaNeo™ MDMA for a prospective clinical trial.

Key Points:

TORONTO, March 26, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA, OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to announce that it had entered into a binding sales agreement with Numinus Wellness Inc. (“Numinus”) (TSX: NUMI, OTCQX: NUMIF) to provide its GMP LaNeo™ MDMA for a prospective clinical trial.
“PharmAla wishes Numinus success in their clinical trial application, and looks forward to supporting them in their efforts,” said Nick Kadysh, Founding CEO, PharmAla Biotech.
The poster, entitled In Vivo Characterization of MBDB and its Enantiomers in C57 and Autism-like BTBR Mice, presents key findings from the development of PharmAla’s proof-of-concept rodent data for its ABA molecule family.
“We thank Dr. Fantegrossi for his exceptional and diligent work, and look forward to receiving academic community feedback on our findings thus far,” said Dr. Harpreet Kaur, Vice President of Research, PharmAla Biotech.

Ayala Pharmaceuticals Announces Completion of Sale of AL102 to Immunome

Retrieved on:

Tuesday, March 26, 2024

OTCQX, Sale, Pharmaceutical industry

MONMOUTH JUNCTION, N.J., March 26, 2024 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced the completion of the previously announced sale of AL102, and related drug candidate AL101, to Immunome, Inc. (Nasdaq: IMNM).

Key Points:

MONMOUTH JUNCTION, N.J., March 26, 2024 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced the completion of the previously announced sale of AL102, and related drug candidate AL101, to Immunome, Inc. (Nasdaq: IMNM).
As per the terms of the sale, Ayala received from Immunome $20 million in cash and 2,175,489 shares of Immunome common stock, and Immunome assumed specified liabilities related to AL102.
Ayala may also receive up to an additional $37.5 million in development and commercial milestone payments.
“We are pleased that AL102 will now be advanced by the highly experienced team at Immunome,” said Ken Berlin, President and CEO of Ayala Pharmaceuticals.

Antibe to File an Application for an Initial Order Under Companies' Creditors Arrangement Act

Retrieved on:

Tuesday, April 9, 2024

Research, FDA, Clinical Trials, Biotechnology, Health, Pharmaceutical, General Health, Other Science, Science, Singapore International Arbitration Centre, TSX, Food, OTCQX

Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSX: ATE, OTCQX: ATBPF) announced that it intends to file an application today with the Ontario Superior Court of Justice (Commercial List) (the "Court") for an Initial Order under the Companies' Creditors Arrangement Act (the "CCAA").

Key Points:

Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSX: ATE, OTCQX: ATBPF) announced that it intends to file an application today with the Ontario Superior Court of Justice (Commercial List) (the "Court") for an Initial Order under the Companies' Creditors Arrangement Act (the "CCAA").
The application seeks an order that would, amongst other things, stay any action by Nuance Pharma to enforce the previously announced confidential ruling from the Singapore International Arbitration Centre requiring Antibe to pay approximately US$24 million to Nuance and would also enable the Company to continue engaging with the U.S. Food and Drug Administration with respect to the previously announced hold on the Company’s planned Phase II trial.
In addition, the Company announced that Amal Khouri and Jennifer McNealey have resigned from its Board of Directors effective April 8, 2024.
The Company thanks both Ms. Khouri and Ms. McNealey for their valuable contributions and wishes them well in their future endeavors.

Largest Grocery Chain in U.S. Adds Yerbaé Across the Country

Retrieved on:

Monday, April 8, 2024

Food, Beverage, Online Retail, Retail, Supermarket, Convenience Store, Pennsylvania State University, Partnership, King Soopers, Fry, OTCQX, HVU, Multimedia, NIL, Grocery store

Yerbaé Brands Corp. (TSX-V: YERB.U; OTCQX: YERBF) (“Yerbaé” or the “Company”), a plant-based energy beverage company, announced its further expansion into the grocery channel with Kroger, the largest U.S. grocery store chain.

Key Points:

Yerbaé Brands Corp. (TSX-V: YERB.U; OTCQX: YERBF) (“Yerbaé” or the “Company”), a plant-based energy beverage company, announced its further expansion into the grocery channel with Kroger, the largest U.S. grocery store chain.
Yerbae's products will now be available in over 1,000 Kroger locations across the country, solidifying its presence in the retail market.
Todd Gibson, co-founder and CEO of Yerbaé, expressed enthusiasm about the partnership, stating, "This partnership with Kroger represents more than just increased distribution.
Yerbaé invites consumers to experience its plant-based energy drinks, now conveniently available in Kroger stores mentioned above starting in third quarter 2024.

Bank of South Carolina Corporation Announces First Quarter Earnings

Retrieved on:

Tuesday, April 9, 2024

Federal Reserve, Federal, Bank, OTCQX

CHARLESTON, S.C., April 9, 2024 /PRNewswire/ -- The Bank of South Carolina Corporation (OTCQX: BKSC) announced unaudited earnings of $1,375,796 or $0.25 basic and diluted earnings per share for the quarter ended March 31, 2024 – a decrease of $212,983, or 13.41%, from earnings for the quarter ended March 31, 2023 of $1,588,779 or $0.29 and $0.28 basic and diluted earnings per share, respectively.

Key Points:

CHARLESTON, S.C., April 9, 2024 /PRNewswire/ -- The Bank of South Carolina Corporation (OTCQX: BKSC) announced unaudited earnings of $1,375,796 or $0.25 basic and diluted earnings per share for the quarter ended March 31, 2024 – a decrease of $212,983, or 13.41%, from earnings for the quarter ended March 31, 2023 of $1,588,779 or $0.29 and $0.28 basic and diluted earnings per share, respectively.
When compared to last quarter, we produced higher net interest income, net income, and book value per share.
These improved results are in large part due to strong commercial loan activity experienced during the quarter that propelled average loan growth of 2.5%.
Meanwhile, credit quality is sound and non-performing assets minimal, and we are encouraged to be ahead of our 2024 profit plan to-date.

Remark Holdings Sets Fiscal Year 2023 Financial Results Call for April 15, 2024, at 4:30 p.m. ET

Retrieved on:

Monday, April 8, 2024

Telephone, Artificial intelligence, OTCQX

LAS VEGAS, April 8, 2024 /PRNewswire/ -- Remark Holdings, Inc. (OTCQX: MARK), a diversified global technology company with leading artificial intelligence ("AI") powered computer vision solutions, today announced the company's conference call to review financial results for its fiscal year ended December 31, 2023, will be held on Monday, April 15th, 2024, at 4:30 p.m. Eastern time.

Key Points:

LAS VEGAS, April 8, 2024 /PRNewswire/ -- Remark Holdings, Inc. (OTCQX: MARK), a diversified global technology company with leading artificial intelligence ("AI") powered computer vision solutions, today announced the company's conference call to review financial results for its fiscal year ended December 31, 2023, will be held on Monday, April 15th, 2024, at 4:30 p.m. Eastern time.
In addition to fiscal year 2023 financial results, management will provide an update on the company's AI businesses in Asia, Europe, Latin America, and the United States and the progress made across its AI platform.
The live conference may be accessed via telephone or online webcast.

KARORA RESOURCES ANNOUNCES MERGER TRANSACTION WITH WESTGOLD RESOURCES

Retrieved on:

Monday, April 8, 2024

TORONTO, April 7, 2024 /CNW/ - Karora Resources Inc. (TSX: KRR) (OTCQX: KRRGF) ("Karora") and Westgold Resources Limited (ASX: WGX) (OTCQX: WGXRF) ("Westgold") have agreed to combine in a merger pursuant to which Westgold will acquire 100% of the issued and outstanding common shares of Karora ("Karora Shares") by way of a statutory plan of arrangement under the Canada Business Corporations Act ("CBCA") ("Transaction").

Key Points:

TORONTO, April 7, 2024 /CNW/ - Karora Resources Inc. (TSX: KRR) (OTCQX: KRRGF) ("Karora") and Westgold Resources Limited (ASX: WGX) (OTCQX: WGXRF) ("Westgold") have agreed to combine in a merger pursuant to which Westgold will acquire 100% of the issued and outstanding common shares of Karora ("Karora Shares") by way of a statutory plan of arrangement under the Canada Business Corporations Act ("CBCA") ("Transaction").
Karora shareholders will receive 2.5241 Westgold fully paid ordinary shares ("Westgold Shares"), A$0.68 (C$0.611) in cash and 0.30 of a share in a new company to be spun-out from Karora ("SpinCo") for each Karora Share held at the closing of the Transaction ("Offer Consideration").
Upon completion of the Transaction, existing Westgold and Karora shareholders will own approximately 50.1% and 49.9% of Enlarged Westgold, respectively.
The Transaction has been unanimously approved by the boards of directors of Westgold and Karora, and Karora's board of directors unanimously recommends that Karora shareholders vote in favour of the Transaction.

Trulieve Cannabis Corp. to Hold First Quarter 2024 Results Conference Call on May 9, 2024

Retrieved on:

Friday, April 5, 2024

Interest, OTCQX, Cannabis

TALLAHASSEE, Fla., April 5, 2024 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., will hold a conference call on Thursday, May 9, 2024 at 8:30 AM Eastern Time following the release of its first quarter 2024 financial results.

Key Points:

TALLAHASSEE, Fla., April 5, 2024 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., will hold a conference call on Thursday, May 9, 2024 at 8:30 AM Eastern Time following the release of its first quarter 2024 financial results.
Chairman, Founder, and Chief Executive Officer Kim Rivers and Chief Financial Officer Wes Getman will participate on the call to review Trulieve's financial and operating results.
Interested parties can join the conference call by dialing in as directed below.
Please dial in 15 minutes prior to the call and ask to join the Trulieve Cannabis Corp. call.